Sol-Gel Technologies (SLGL) Current Leases (2019 - 2025)
Sol-Gel Technologies (SLGL) reported Current Leases of $495000.0 for Q4 2025, up 15.12% year-over-year from $430000.0 in Q4 2024, and up 0.81% on a QoQ basis from $491000.0 in Q3 2025.
Sol-Gel Technologies (SLGL) has 7 years of Current Leases data on file, last reported at $495000.0 in Q4 2025.
- Quarterly Current Leases rose 15.12% year-over-year to $495000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $495000.0 (up 15.12% YoY) and the FY2025 annual result came in at $495000.0, up 15.12% from the prior year.
- Current Leases rose to $495000.0 in Q4 2025 per SLGL's latest filing, from $491000.0 in the prior quarter.
- Across five years, Current Leases topped out at $781000.0 in Q4 2021 and bottomed at $376000.0 in Q2 2024.
- The 5-year median for Current Leases is $493000.0 (2025), against an average of $548200.0.
- The widest annual swing landed in 2021, when Current Leases climbed 28.35%; it then plunged 38.23% in 2023.
- Tracing SLGL's Current Leases over 5 years: stood at $781000.0 in 2021, then declined by 8.07% to $718000.0 in 2022, then slumped by 37.74% to $447000.0 in 2023, then decreased by 3.8% to $430000.0 in 2024, then advanced by 15.12% to $495000.0 in 2025.
- Per Business Quant, the three latest SLGL Current Leases figures stand at $495000.0 (Q4 2025), $491000.0 (Q3 2025), and $482000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - | 495,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 495,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 482,000.00 |
| Mar 31, 2025 | 433,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Sep 30, 2024 | 384,000.00 |
| Jun 30, 2024 | 376,000.00 |
| Mar 31, 2024 | 386,000.00 |
| Dec 31, 2023 | 447,000.00 |
| Sep 30, 2023 | 467,000.00 |
| Jun 30, 2023 | 433,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Dec 31, 2022 | 718,000.00 |
| Sep 30, 2022 | 689,000.00 |
| Jun 30, 2022 | 701,000.00 |
| Mar 31, 2022 | 766,000.00 |
| Dec 31, 2021 | 781,000.00 |
| Sep 30, 2021 | 652,000.00 |
| Jun 30, 2021 | 649,000.00 |
| Mar 31, 2021 | 640,000.00 |
| Dec 31, 2020 | 673,000.00 |
| Sep 30, 2020 | 508,000.00 |
| Jun 30, 2020 | 525,000.00 |
| Mar 31, 2020 | 525,000.00 |
| Dec 31, 2019 | 672,000.00 |
| Sep 30, 2019 | 660,000.00 |
| Jun 30, 2019 | 526,000.00 |
| Mar 31, 2019 | 647,000.00 |